# MAPS PrEP Van Study

> **NCT06908252** · PHASE4 · RECRUITING · sponsor: **Duke University** · enrollment: 20 (estimated)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** Pre-Exposure Prophylaxis (PrEP)

## Key facts

- **NCT ID:** NCT06908252
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-17
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-07-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-01-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06908252

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06908252, "MAPS PrEP Van Study". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT06908252. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*